Tenon Medical announced a strategic expansion of its U.S. patent portfolio after receiving USPTO Notices of Allowance for multiple patent applications expected to issue in 2026. The newly allowed claims add to 10 patents issued in 2025 and strengthen protection for systems and methods tied to its SI joint fusion technologies, as the company reported a portfolio of 29 issued U.S. patents, nine issued international patents, and 31 pending applications.
Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Tenon Medical Inc. published the original content used to generate this news brief via ACCESS Newswire (Ref. ID: 202602180835ACCESSWRNAPR_____1138459) on February 18, 2026, and is solely responsible for the information contained therein.